c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer (Q30541608)

17 August 2017

c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer (English)

1 reference

17 August 2017

1 reference

3

1 reference

Cristian Rodriguez-Aguayo

PubMed publication ID

24 June 2017

Arturo Chavez-Reyes

7

0 references

object named as

Cristian Rodriguez-Aguayo

6

0 references

Anil K. Sood

18

object named as

Anil K Sood

1 reference

17 August 2017

Pablo Vivas-Mejia

1

1 reference

17 August 2017

Juliana Maria Benito

2

1 reference

17 August 2017

Hee-Dong Han

4

1 reference

17 August 2017

Lingegowda Mangala

5

1 reference

17 August 2017

Yvonne G Lin

8

1 reference

17 August 2017

Mark S Carey

9

1 reference

17 August 2017

Alpa M Nick

10

1 reference

17 August 2017

Rebecca L Stone

11

1 reference

17 August 2017

Hye Sun Kim

12

1 reference

17 August 2017

Francois-Xavier Claret

13

1 reference

17 August 2017

William Bornmann

14

1 reference

17 August 2017

Bryan T J Hennessy

15

1 reference

17 August 2017

Angela Sanguino

16

1 reference

17 August 2017

Zhengong Peng

17

1 reference

17 August 2017

Gabriel Lopez-Berestein

19

1 reference

17 August 2017

language of work or name

English

0 references

publication date

22 December 2009

1 reference

17 August 2017

Clinical Cancer Research

1 reference

17 August 2017

16

1 reference

17 August 2017

1

1 reference

17 August 2017

184-194

1 reference

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

The c-Jun N-terminal kinase JNK functions upstream of Aurora B to promote entry into mitosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Pharmacodynamic markers of perifosine efficacy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Rational drug redesign to overcome drug resistance in cancer therapy: imatinib moving target

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Features of selective kinase inhibitors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Tyrosine kinase inhibitors and the dawn of molecular cancer therapeutics

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

A small molecule-kinase interaction map for clinical kinase inhibitors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Inhibition of tumor growth, angiogenesis, and tumor cell proliferation by a small molecule inhibitor of c-Jun N-terminal kinase.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Molecularly targeted therapy: have the floodgates opened?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Docetaxel versus paclitaxel for adjuvant treatment of ovarian cancer: case-control analysis of toxicity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Mammalian MAP kinase signalling cascades

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Signal transduction by the JNK group of MAP kinases

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Inhibition of c-Jun N-terminal kinase 2 expression suppresses growth and induces apoptosis of human tumor cells in a p53-dependent manner

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

The stress-activated protein kinase subfamily of c-Jun kinases

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Relationships between the structure of taxol analogs and their antimitotic activity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

c-Jun NH2-terminal kinase 1 is a critical regulator for the development of gastric cancer in mice

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Non-parametric quantification of protein lysate arrays

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716580

Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20028751

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20028751

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1078-0432.CCR-09-1180

1 reference

17 August 2017

1 reference

17 August 2017

PubMed publication ID

20028751

1 reference